Zobrazeno 1 - 10
of 49
pro vyhledávání: '"R D, Molano"'
Autor:
S. R. Cechin, I. Pérez-Álvarez, E. Fenjves, R. D. Molano, A. Pileggi, P-O. Berggren, C. Ricordi, R. L. Pastori Ph.D.
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Exenatide is an analog of the incretin hormone glucagon-like peptide (GLP-1) that is used for the treatment of T2D for their metabolic effects. In addition to its insulinotropic effects, exenatide increases functional islet mass and improves their su
Externí odkaz:
https://doaj.org/article/83db0f1ab9064c8da6fed01474ffc7db
Autor:
R. Misawa, C. Ricordi, A. Miki, S. Barker, R. D. Molano, A. Khan, S. Miyagawa, L. Inverardi, R. Alejandro, A. Pileggi, H. Ichii M.D., Ph.D.
Publikováno v:
Cell Transplantation, Vol 21 (2012)
The selection of enzyme blend is critical for the success of human islet isolations. Liberase HI collagenase (Roche) was introduced in the 1990s and had been widely used for clinical islet transplantation. More recently, a blend collagenase NB1 has b
Externí odkaz:
https://doaj.org/article/d1323388c03d4d579ba77727ff0aa62b
Autor:
Behrouz Ashrafi, R. D. Molano, Phillip Ruiz, Christopher A. Fraker, Ernesto A. Pretto, Mohammad Hossein Tootoonchi, Ryan Bardsley
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 172:797-805
Background Research into injectable volatile anesthetics has been ongoing for approximately 40 years, with limited success, in an attempt to address the deficiencies of inhalational anesthesia. The purpose of this work was to formulate and optimize v
Autor:
A. Mita, C. Ricordi, S. Messinger, A. Miki, R. Misawa, S. Barker, R. D. Molano, R. Haertter, A. Khan, S. Miyagawa, A. Pileggi, L. Inverardi, R. Alejandro, B. J. Hering, H. Ichii M.D., Ph.D.
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Islet isolation and purification using a continuous density gradient may reduce the volume of tissue necessary for implantation into patients, therefore minimizing the risks associated with intraportal infusion in islet transplantation. On the other
Externí odkaz:
https://doaj.org/article/9c4bc89c77554fe4afe203954ac206a4
Publikováno v:
CellR4-- repair, replacement, regeneration,reprogramming. 2(4)
Autor:
Camillo Ricordi, T Yamamoto, R. D. Molano, Antonello Pileggi, Ryosuke Misawa, Atsushi Miki, Atsuyoshi Mita, Nosratola D. Vaziri, Hirohito Ichii, Yasunaru Sakuma
Publikováno v:
PLoS ONE
Miki, A; Ricordi, C; Sakuma, Y; Yamamoto, T; Misawa, R; Mita, A; et al.(2018). Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation. PLOS ONE, 13(5), e0196570. doi: 10.1371/journal.pone.0196570. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/78t5q3cb
PLoS ONE, Vol 13, Iss 5, p e0196570 (2018)
Miki, A; Ricordi, C; Sakuma, Y; Yamamoto, T; Misawa, R; Mita, A; et al.(2018). Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation. PLOS ONE, 13(5), e0196570. doi: 10.1371/journal.pone.0196570. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/78t5q3cb
PLoS ONE, Vol 13, Iss 5, p e0196570 (2018)
Author(s): Miki, Atsushi; Ricordi, Camillo; Sakuma, Yasunaru; Yamamoto, Toshiyuki; Misawa, Ryosuke; Mita, Atsuyoshi; Molano, Ruth D; Vaziri, Nosratola D; Pileggi, Antonello; Ichii, Hirohito | Abstract: BackgroundType 1 and Type 2 diabetes mellitus (T
Autor:
N Cautero, R. D. Molano, Rodolfo Alejandro, Norma S. Kenyon, Luca Inverardi, Alessandra Ranuncoli, Michele Masetti, Camillo Ricordi
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Cell Transplantation, Vol 9 (2000)
Europe PubMed Central
Cell Transplantation, Vol 9 (2000)
Transplantation of pancreatic islets of Langerhans as a therapeutic approach for treatment of type I diabetes offers an alternative to subcutaneous insulin injections. Normalization of blood glucose levels by transplanted islets may prevent the devel
Autor:
Susana Villate, Camillo Ricordi, R. D. Molano, Christopher A. Fraker, Antonello Pileggi, Silvia Álvarez-Cubela, Luca Inverardi, Sirlene Cechin, Jaime A. Giraldo, Juan Domínguez-Bendala
Publikováno v:
Stem Cells Translational Medicine. 3:277-289
The possibility of using human embryonic stem (hES) cell-derived β cells as an alternative to cadaveric islets for the treatment of type 1 diabetes is now widely acknowledged. However, current differentiation methods consistently fail to generate me
Autor:
Antonello Pileggi, Manana Kakabadze, Camillo Ricordi, R. D. Molano, Ekaterine Berishvili, G Loladze, Zurab Kakabadze, G Shatirishvili, Konstantine Mardaleishvili, Sanjeev Gupta
Publikováno v:
American Journal of Transplantation, Vol. 13, No 10 (2013) pp. 2550-2557
Transplantation of mature islets into portal vein has been most effective thus far, although attrition of transplanted islets constitutes a major limitation, and alternative approaches are required. We analyzed the mechanisms by which islets engrafte
Autor:
Paola Maffi, Antonello Pileggi, Domenico Corradi, Sara Tezza, R. D. Molano, Francesca D'Addio, Francesca Gatti, Paolo Fiorina, Melissa Chin, Mohamed H. Sayegh, Carmen Fotino, Antonio Secchi, Fabio Grassi, Maria Elena Ferrero, Rita Gatti, Andrea Vergani, Camillo Ricordi, Michele Podetta, Roberto Bassi
Publikováno v:
Diabetes
The lymphocytic ionotropic purinergic P2X receptors (P2X1R-P2X7R, or P2XRs) sense ATP released during cell damage-activation, thus regulating T-cell activation. We aim to define the role of P2XRs during islet allograft rejection and to establish a no